Zebra Medical Vision, Medsynapic begin new AI partnership

Zebra Medical Vision has announced a new partnership with Medsynapic Pvt Ltd, a healthcare IT company based out of Pune, India.

As a result of this relationship, Zebra Medical Vision’s AI solution, AI1, will be used to provide care to more than 40 million patients covered by India’s Apollo Hospitals health system.

“Medsynaptic is proud to work with Zebra Medical Vision team to enable such a large scale, cloud-first AI deployment,” Dr. Ashish Dhawad, co-founder and CEO of Medsynaptic, said in a prepared statement. “Zebra-Med’s AI1 cloud based offering is the perfect fit for us as it leverages many of our core technologies such as zero footprint PACS and RIS and smart worklist.”

Eyal Gura, co-founder and CEO of Zebra Medical Vision, said in the same statement his team was “honored to join forces” with Medsynaptic and “make AI accessible for patients across India.”

More information on this partnership is available on Zebra Medical Vision’s website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.